Bispecific gp100 Peptide-HLA-directed CD3 T Cell Engager

DBCAT005658Therapeutic category

A DrugBank category of 1 drug. 1 of them is approved.

What you can answer from here — as of April 30, 2022

1DrugEach linked to its full drug card

Listed above

1Drug targetEvery drug–target pair in the class, with bond type

4Marketed productsAcross the regions we cover, with dosage forms and routes

1Route of administrationHow the drugs in this class are given

Which targets do Bispecific gp100 Peptide-HLA-directed CD3 T Cell Engager share, and which companies have late-stage candidates in this class?

Create a free account or log in to explore the full data card.